P. Arrabal-Durán

Level of concordance between two risk-assessment models for predicting venous thromboembolism in medical patients at admission

A. Herranz-Alonso, M. Sanjurjo-Sáez, E. Duran-Garcia, 2015, European journal of hospital pharmacy. Science and practice.

Switching to a rilpivirine/emtricitabine/tenofovir single‐tablet regimen in RNA‐suppressed patients infected with human immunodeficiency virus 1: Effectiveness, safety and costs at 96 weeks

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2017, International journal of clinical practice.

Pharmaceutical interventions in prescriptions for patients admitted with chronic renal failure.

M. Durán-García, M. Sanjurjo-Sáez, P. Arrabal-Durán, 2014, Nefrología.